Stockscreener 앱 받기
0.182
0.55%
0.001
전일 마감가:
$0.181
열려 있는:
$0.1841
하루 거래량:
597.26K
Relative Volume:
0.14
시가총액:
$2.67M
수익:
$1.10M
순이익/손실:
$-11.23M
주가수익비율:
-0.0899
EPS:
-2.025
순현금흐름:
$-6.61M
1주 성능:
-9.00%
1개월 성능:
-37.35%
6개월 성능:
-69.84%
1년 성능:
-89.23%
1일 변동 폭
$0.173
$0.1904
1주일 범위
$0.173
$0.20
52주 변동 폭
$0.173
$2.14
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.182 | 2.68M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportZero Gamma Level - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Matinas BioPharma (MTNB) to merge into new GH Power International parent - stocktitan.net
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineDividend Increase Stocks - Vinanet
Matinas BioPharma (NYSE: MTNB) outlines GH Power deal and 91% post-merger stake - Stock Titan
Matinas BioPharma (MTNB) and GH Power set 91/9 split in NYSE American deal - Stock Titan
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
12 Health Care Stocks Moving In Monday's Intraday SessionEntera Bio (NASDAQ:ENTX), Gossamer Bio (NASDA - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Matinas Biopharma Holdings, Inc. Revenue Breakdown – AMEX:MTNB - TradingView
Trending Stocks Today | Matinas BioPharma Surges 44.65% Post-Market - Moomoo
Matinas BioPharma Ends At-The-Market Sales Agreement - TipRanks
Matinas BiopharmaBtig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026SEC Filing - TradingView
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties - TradingView
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate M - Hydrogen Central
[425] Matinas BioPharma Holdings, Inc. Business Combination Communication - Stock Titan
Matinas BioPharma Holdings Inc (NYSE: MTNB) Share Price, MTNB Stock News, MTNB Share Price & Updates - Kalkine
Matinas BioPharma (NYSE: MTNB) to combine with GH Power in new Ontario holdco - Stock Titan
GH Power Goes Public via Matinas BioPharma Merger - Fuel Cells Works
GH Power To Go Public Through Business Combination With Matinas BioPharma - Pulse 2.0
Nasdaq Surges Over 100 Points; Bank of America Earnings Top Views - Sahm
Hezbay builds 9.54% position in Matinas BioPharma (MTNB) - Stock Titan
Matinas BioPharma forms business tie-up with GH Power to create clean energy and green hydrogen company - ROI-NJ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday SessionNextCure (NASDAQ:NXTC), Shuttle Pharmaceutic - Benzinga
United StatesLowenstein Represents Matinas BioPharma In Strategic Business Combination With GH Power And Divestiture Of Matinas BioPharma Nanotechnologies, Inc. - Mondaq
GH Power to go public via merger with Matinas BioPharma By Investing.com - Investing.com Nigeria
GH Power to go public via Matinas BioPharma merger - scanx.trade
GH Power to go public via merger with Matinas BioPharma - Investing.com
GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public through Business Combination with Matinas BioPharma - Yahoo Finance
Matinas BioPharma to Merge with GH Power, Selling LNC Platform to Azurity in Major Clean Energy & Pharma Deal - Minichart
Matinas BioPharma to Merge with GH Power International - TipRanks
Matinas BioPharma (MTNB) Engages in Strategic Business Combinati - GuruFocus
Matinas BioPharma (NYSE: MTNB) plans GH Power merger and $21.5M Azurity sale - Stock Titan
Matinas BioPharma (NYSE: MTNB) plans GH Power merger and $21.5M Azurity asset sale - Stock Titan
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):